The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Amino-N'-[2-chloro-10-oxo-9,10-dihydroanthracene-9-ylidene]benzohydrazide ID: ALA2283224
PubChem CID: 76316309
Max Phase: Preclinical
Molecular Formula: C21H16ClN3O2
Molecular Weight: 377.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1cccc(C(=O)N/N=C2\c3cc(Cl)ccc3C(=O)C3C=CC=CC23)c1
Standard InChI: InChI=1S/C21H16ClN3O2/c22-13-8-9-17-18(11-13)19(15-6-1-2-7-16(15)20(17)26)24-25-21(27)12-4-3-5-14(23)10-12/h1-11,15-16H,23H2,(H,25,27)/b24-19-
Standard InChI Key: JKQVGXSXQYCQTC-CLCOLTQESA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.2751 -2.2391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2740 -3.0682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9908 -3.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7052 -3.0677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7023 -2.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9890 -1.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4173 -1.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1353 -2.2301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4142 -0.9949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5627 -1.8280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1384 -3.0568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8523 -3.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2819 -4.2949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5664 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2802 -3.4719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9974 -3.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9978 -2.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2750 -1.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5650 -2.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5686 -4.7095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8592 -4.2951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1534 -4.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1517 -5.5205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8616 -5.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5686 -5.5210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2711 -0.9910 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.9974 -4.7056 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
1 10 1 0
8 11 1 0
11 12 2 0
12 21 1 0
12 14 1 0
20 13 1 0
13 15 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
18 26 1 0
13 27 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.83Molecular Weight (Monoisotopic): 377.0931AlogP: 3.61#Rotatable Bonds: 2Polar Surface Area: 84.55Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.74CX Basic pKa: 2.97CX LogP: 2.98CX LogD: 2.98Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.62Np Likeness Score: -0.51
References 1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0 ]